These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 34411400)
1. Bile acid dysmetabolism in the gut-microbiota-liver axis under hepatitis C virus infection. Inoue T; Funatsu Y; Ohnishi M; Isogawa M; Kawashima K; Tanaka M; Moriya K; Kawaratani H; Momoda R; Iio E; Nakagawa H; Suzuki Y; Matsuura K; Fujiwara K; Nakajima A; Yoshiji H; Nakayama J; Tanaka Y Liver Int; 2022 Jan; 42(1):124-134. PubMed ID: 34411400 [TBL] [Abstract][Full Text] [Related]
2. Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease. Adams LA; Wang Z; Liddle C; Melton PE; Ariff A; Chandraratna H; Tan J; Ching H; Coulter S; de Boer B; Christophersen CT; O'Sullivan TA; Morrison M; Jeffrey GP Liver Int; 2020 Jun; 40(6):1356-1365. PubMed ID: 32243703 [TBL] [Abstract][Full Text] [Related]
3. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis. Luo Y; Decato BE; Charles ED; Shevell DE; McNaney C; Shipkova P; Apfel A; Tirucherai GS; Sanyal AJ JHEP Rep; 2022 Jan; 4(1):100392. PubMed ID: 34977519 [TBL] [Abstract][Full Text] [Related]
4. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice. Xu M; Shen Y; Cen M; Zhu Y; Cheng F; Tang L; Zheng X; Kim JJ; Dai N; Hu W J Crohns Colitis; 2021 Jul; 15(7):1197-1210. PubMed ID: 33417675 [TBL] [Abstract][Full Text] [Related]
5. Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis. Aliwa B; Horvath A; Traub J; Feldbacher N; Habisch H; Fauler G; Madl T; Stadlbauer V J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2676-2691. PubMed ID: 37767786 [TBL] [Abstract][Full Text] [Related]
6. Modulation of bile acid profile by gut microbiota in chronic hepatitis B. Wang X; Chen L; Wang H; Cai W; Xie Q J Cell Mol Med; 2020 Feb; 24(4):2573-2581. PubMed ID: 31925905 [TBL] [Abstract][Full Text] [Related]
7. Gut Dysbiosis Associated With Hepatitis C Virus Infection. Inoue T; Nakayama J; Moriya K; Kawaratani H; Momoda R; Ito K; Iio E; Nojiri S; Fujiwara K; Yoneda M; Yoshiji H; Tanaka Y Clin Infect Dis; 2018 Aug; 67(6):869-877. PubMed ID: 29718124 [TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis. Wang Y; Gao X; Zhang X; Xiao Y; Huang J; Yu D; Li X; Hu H; Ge T; Li D; Zhang T mSystems; 2019 Dec; 4(6):. PubMed ID: 31848302 [TBL] [Abstract][Full Text] [Related]
9. Ex vivo metabolism kinetics of primary to secondary bile acids via a physiologically relevant human faecal microbiota model. Ng DZW; Low A; Tan AJH; Ong JH; Kwa WT; Lee JWJ; Chan ECY Chem Biol Interact; 2024 Aug; 399():111140. PubMed ID: 38992765 [TBL] [Abstract][Full Text] [Related]
10. Isolation of mucosa-associated microbiota dysbiosis in the ascending colon in hepatitis C virus post-sustained virologic response cirrhotic patients. Midori Y; Nosaka T; Hiramatsu K; Akazawa Y; Tanaka T; Takahashi K; Naito T; Matsuda H; Ohtani M; Nakamoto Y Front Cell Infect Microbiol; 2024; 14():1371429. PubMed ID: 38650735 [TBL] [Abstract][Full Text] [Related]
11. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism. Hu X; Bonde Y; Eggertsen G; Rudling M J Intern Med; 2014 Jan; 275(1):27-38. PubMed ID: 24118394 [TBL] [Abstract][Full Text] [Related]
12. Bile acid metabolism dysregulation associates with cancer cachexia: roles of liver and gut microbiome. Feng L; Zhang W; Shen Q; Miao C; Chen L; Li Y; Gu X; Fan M; Ma Y; Wang H; Liu X; Zhang X J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1553-1569. PubMed ID: 34585527 [TBL] [Abstract][Full Text] [Related]
13. Multi-omics reveals deoxycholic acid modulates bile acid metabolism via the gut microbiota to antagonize carbon tetrachloride-induced chronic liver injury. Zhang L; Zheng Z; Huang H; Fu Y; Chen T; Liu C; Yi Q; Lin C; Zeng Y; Ou Q; Zeng Y Gut Microbes; 2024; 16(1):2323236. PubMed ID: 38416424 [TBL] [Abstract][Full Text] [Related]
14. Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation. Xu M; Cen M; Shen Y; Zhu Y; Cheng F; Tang L; Hu W; Dai N Dig Dis Sci; 2021 Feb; 66(2):568-576. PubMed ID: 32198567 [TBL] [Abstract][Full Text] [Related]
15. Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota. Jin D; Huang K; Xu M; Hua H; Ye F; Yan J; Zhang G; Wang Y Gut Microbes; 2022; 14(1):2120744. PubMed ID: 36067404 [TBL] [Abstract][Full Text] [Related]
16. Effects of direct anti-viral agents on the gut microbiota in patients with chronic hepatitis C. Huang PY; Chen CH; Tsai MJ; Yao CC; Wang HM; Kuo YH; Chang KC; Hung CH; Chuah SK; Tsai MC J Formos Med Assoc; 2023 Feb; 122(2):157-163. PubMed ID: 36155707 [TBL] [Abstract][Full Text] [Related]
17. The gut bacterium Streidl T; Karkossa I; Segura Muñoz RR; Eberl C; Zaufel A; Plagge J; Schmaltz R; Schubert K; Basic M; Schneider KM; Afify M; Trautwein C; Tolba R; Stecher B; Doden HL; Ridlon JM; Ecker J; Moustafa T; von Bergen M; Ramer-Tait AE; Clavel T Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33382950 [No Abstract] [Full Text] [Related]
18. Bile acids promote the expression of hepatitis C virus in replicon-harboring cells. Chang KO; George DW J Virol; 2007 Sep; 81(18):9633-40. PubMed ID: 17609266 [TBL] [Abstract][Full Text] [Related]
19. Western Diet Changes Gut Microbiota and Ameliorates Liver Injury in a Mouse Model with Human-Like Bile Acid Composition. Iwamoto J; Honda A; Miyazaki T; Monma T; Ueda H; Morishita Y; Yara SI; Hirayama T; Ikegami T Hepatol Commun; 2021 Dec; 5(12):2052-2067. PubMed ID: 34558859 [TBL] [Abstract][Full Text] [Related]
20. Organic anion-transporting polypeptide 1a4 (Oatp1a4) is important for secondary bile acid metabolism. Zhang Y; Csanaky IL; Selwyn FP; Lehman-McKeeman LD; Klaassen CD Biochem Pharmacol; 2013 Aug; 86(3):437-45. PubMed ID: 23747753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]